SCHEMBL456350

SCHEMBL456350

Clc1[c]c(Cl)c(-c2ccccc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 1/20 0.44
CTRC Q99895 2/20 0.39
CSNK2A1 P68400 2/20 0.37
CYP1A2 P05177 1/20 0.37
BACE1 P56817 1/20 0.36
ALOX5 P09917 1/20 0.35
ALDH1A1 P00352 5/20 0.35
HSD17B10 Q99714 2/20 0.34
HPGD P15428 2/20 0.34
BCL2L1 Q07817 1/20 0.34
MAPK1 P28482 1/20 0.34
KDM4E B2RXH2 1/20 0.34
LMNA P02545 1/20 0.34
GLA P06280 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
ESR1 P03372 1/20 0.34
MEN1 O00255 1/20 0.33
HTT P42858 1/20 0.33
KMT2A Q03164 1/20 0.33
ESR2 Q92731 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7703851 0.83 GSTP1 (0.49) SMN1; SMN2MEN1KMT2ATSHR
SCHEMBL6068229 0.82 AHR (0.39) CYP2A6CYP1A2ALOX5KDM4ELMNA
SCHEMBL15287170 0.79 TDO2 (0.41) ALOX5SMN1; SMN2MEN1KMT2AESR2
SCHEMBL457904 0.78 CYP2A6 (0.41) CYP2A6CTRCCSNK2A1CYP1A2BACE1
SCHEMBL7814278 0.78 CYP2A6 (0.41) CYP2A6CTRCCSNK2A1CYP1A2BACE1
SCHEMBL6206554 0.78 CYP2A6 (0.41) CYP2A6CTRCCSNK2A1CYP1A2BACE1
SCHEMBL454901 0.78 ALDH1A1 (0.41) CYP2A6CTRCCSNK2A1CYP1A2BACE1
SCHEMBL455577 0.78 ALDH1A1 (0.41) CYP2A6CTRCCSNK2A1CYP1A2BACE1
SCHEMBL7814348 0.78 CYP2A6 (0.41) CYP2A6CTRCCSNK2A1CYP1A2BACE1
SCHEMBL12503755 0.78 CYP2A6 (0.41) CYP2A6CTRCCSNK2A1CYP1A2BACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1423119-A4 HETEROBICYCLES FKBP-LIGANDS AGOURON PHARMA (US) 2005-04-13 EP claimed
EP-1423119-A1 HETEROBICYCLES FKBP-LIGANDS Agouron Pharmaceuticals, Inc. (US) 2004-06-02 EP claimed
WO-2002089806-A1 HETEROBICYCLES FKBP-LIGANDS AGOURON PHARMACEUTICALS, INC. (US) 2002-11-14 WO claimed
US-9307767-B2 Herbicidally and insecticidally active thiazolopyridinones BAYER INTELLECTUAL PROPERTY GMBH (DE) 2016-04-12 US disclosed
EP-2831084-B1 HERBICIDAL AND INSECTICIDAL THIAZOLOPYRIDINONES BAYER IP GMBH (DE) 2016-03-23 EP disclosed
US-20150045217-A1 Herbicidally and Insecticidally Active Thiazolopyridinones BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2015-02-12 US disclosed
EP-2831084-A1 HERBICIDALLY AND INSECTICIDALLY ACTIVE THIAZOLOPYRIDINONES Bayer Intellectual Property GmbH (DE) 2015-02-04 EP disclosed
WO-2013144096-A1 HERBICIDALLY AND INSECTICIDALLY ACTIVE THIAZOLOPYRIDINONES BAYER INTELLECTUAL PROPERTY GMBH (DE) 2013-10-03 WO disclosed
EP-2614053-A1 METHOD FOR PRODUCING PYRIDAZINONE COMPOUNDS AND INTERMEDIATE THEREOF SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2013-07-17 EP disclosed
WO-2012033225-A1 METHOD FOR PRODUCING PYRIDAZINONE COMPOUNDS AND INTERMEDIATE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-03-15 WO disclosed
US-4952580-A NEMATOCIDES, ANTHELMINTICS FMC CORPORATION (US) 1990-08-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150045217-A1 Herbicidally and Insecticidally Active Thiazolopyridinones CBR3, DDT, CBR1 CYP2A6 486/4885CTRC 565/4885CSNK2A1 3051/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.